Literature DB >> 24499751

Outcomes of pregnancy in women with hereditary hemorrhagic telangiectasia.

Els M de Gussem1, Andrea Y Lausman, Aarin J Beder, Christine P Edwards, Marco H Blanker, Karel G Terbrugge, Johannes J Mager, Marie E Faughnan.   

Abstract

OBJECTIVE: To describe pregnancy outcomes in women with hereditary hemorrhagic telangiectasia (HHT).
METHODS: This was a retrospective descriptive study of women with HHT (18-55 years of age) from the Toronto HHT Database using a telephone questionnaire regarding pregnancy, delivery, and neonatal outcomes.
RESULTS: A total of 244 pregnancies were reported in 87 women with HHT. Miscarriages occurred in 20%. Hereditary hemorrhagic telangiectasia-related complications included minor hemoptysis during two pregnancies (1.1%) and hemothorax during four pregnancies (2.1%). One patient presenting with a hemothorax had presented during a previous pregnancy with a transient ischemic attack, most likely resulting from paradoxical emboli. One patient presented with an intracranial hemorrhage, and one patient presented with heart failure. These complications occurred in women previously unscreened and untreated for arteriovenous malformations. Other complications not clearly related to HHT were deep vein thrombosis (n=1), pulmonary embolism (n=1), myocardial infarction (n=1), and myocardial ischemia (n=1). Women noticed an increased frequency of epistaxis and development of new telangiectases during pregnancy. Epidural or spinal anesthesia was performed in 92 of 185 deliveries (50%) without complications. None of these women had undergone screening for spinal arteriovenous malformation before anesthesia.
CONCLUSION: Women with HHT who have not been screened for arteriovenous malformations are at risk for serious pregnancy complications.

Entities:  

Mesh:

Year:  2014        PMID: 24499751     DOI: 10.1097/AOG.0000000000000120

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

Review 1.  Pulmonary arteriovenous malformations: what the interventional radiologist needs to know.

Authors:  Andrea Contegiacomo; Annemilia Del Ciello; Rossella Rella; Nico Attempati; Davide Coppolino; Anna Rita Larici; Carmine Di Stasi; Giuseppe Marano; Riccardo Manfredi
Journal:  Radiol Med       Date:  2019-06-17       Impact factor: 3.469

2.  Expansion of pulmonary arteriovenous malformations after grand mal seizures and other circumstances of PAVM growth.

Authors:  Ami Schattner; Ina Dubin
Journal:  BMJ Case Rep       Date:  2019-08-10

Review 3.  Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects.

Authors:  Nathaniel M Meier; Michael L Foster; John T Battaile
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 4.  Pulmonary arteriovenous malformations.

Authors:  Claire L Shovlin
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

5.  Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.

Authors:  Adrienne M Hammill; Katie Wusik; Raj S Kasthuri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 6.  Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know.

Authors:  Claire S Kaufman; Jamie McDonald; Heather Balch; Kevin Whitehead
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

7.  Osler-Weber-Rendu syndrome: an anaesthetic challenge?

Authors:  Diana Chieira; Luis Conceição; Edgar Semedo; Valentina Almeida
Journal:  BMJ Case Rep       Date:  2016-04-28

Review 8.  Maternal Genetic Disorders in Pregnancy.

Authors:  Sarah Harris; Neeta L Vora
Journal:  Obstet Gynecol Clin North Am       Date:  2018-06       Impact factor: 2.844

9.  Maternal and Fetal Outcomes in Women with Brain Arteriovenous Malformation Rupture during Pregnancy.

Authors:  Kimberly L Yan; Nerissa U Ko; Steven W Hetts; Shantel Weinsheimer; Adib A Abla; Michael T Lawton; Helen Kim
Journal:  Cerebrovasc Dis       Date:  2021-02-26       Impact factor: 2.762

10.  Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.

Authors:  Claire L Shovlin
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.